{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:07:46Z","timestamp":1778591266439,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.atherosclerosis.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T15:28:59Z","timestamp":1557242939000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population"],"prefix":"10.1016","volume":"286","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-0266","authenticated-orcid":false,"given":"Ayodeji","family":"Awoyemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Tr\u00f8seid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svein","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (*)","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker Paul","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib10","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/s41598-018-22076-4","article-title":"Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque","volume":"8","author":"Carnevale","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1160\/TH16-11-0857","article-title":"Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production","volume":"117","author":"Nocella","year":"2017","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2016-11-754416","article-title":"Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2","volume":"130","author":"Jackel","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"e47713","DOI":"10.1371\/journal.pone.0047713","article-title":"High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.micinf.2005.10.006","article-title":"The role of lipopolysaccharide-binding protein in modulating the innate immune response","volume":"8","author":"Zweigner","year":"2006","journal-title":"Microb. Infect."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib15","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1128\/MCB.16.7.3490","article-title":"The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF\/STAT\/3 and other cytokine-inducible nuclear proteins","volume":"16","author":"Schumann","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","article-title":"CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein","volume":"249","author":"Wright","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","article-title":"Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib19","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1111\/bph.14483","article-title":"Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis","volume":"175","author":"Kiouptsi","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2019.05.004_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114514004127","article-title":"Dietary effects on human gut microbiome diversity","volume":"113","author":"Xu","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MCO.0000000000000209","article-title":"Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk","volume":"18","author":"Murphy","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib22","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1161\/ATVBAHA.118.311233","article-title":"Impact of gut microbiota and diet on the development of atherosclerosis in apoe(-\/-) mice","volume":"38","author":"Lindskog Jonsson","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajcn\/81.3.583","article-title":"Influence of long-term intervention with dietary counseling, long-chain n\u22123 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia1\u20133","volume":"81","author":"Hjerkinn","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/dc08-1710","article-title":"Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia","volume":"32","author":"Troseid","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000481519","article-title":"Gut microbiota-dependent modulation of energy metabolism","volume":"10","author":"Heiss","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fmicb.2016.00185","article-title":"Intestinal short chain fatty acids and their link with diet and human Health","volume":"7","author":"Rios-Covian","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","article-title":"A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis","volume":"124","author":"Brandsma","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib30","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/IAI.64.5.1762-1769.1996","article-title":"Human monocyte CD14 is upregulated by lipopolysaccharide","volume":"64","author":"Landmann","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122645","article-title":"Impact of omega-3 fatty acids on the gut microbiota","volume":"18","author":"Costantini","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.gendis.2018.07.001","article-title":"Inflammation and intestinal leakiness in older HIV+ individuals with fish oil treatment","volume":"5","author":"Zhang","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00394-015-0900-7","article-title":"Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study","volume":"55","author":"Umoh","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2215\/CJN.03100315","article-title":"Associations of soluble CD14 and endotoxin with mortality, cardiovascular disease, and progression of kidney disease among patients with CKD","volume":"10","author":"Poesen","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/ATVBAHA.112.300421","article-title":"Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults","volume":"33","author":"Reiner","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3796359","article-title":"Association study of gut flora in coronary Heart disease through high-throughput sequencing","volume":"2017","author":"Cui","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40168-018-0441-4","article-title":"Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction","volume":"6","author":"Zhou","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2011.06.001","article-title":"Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease--results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC)","volume":"219","author":"Lepper","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.05.004_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019304095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019304095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T23:25:35Z","timestamp":1607642735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019304095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"alternative-id":["S0021915019304095"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.05.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}